SSStefan Siewert

Stefan Siewert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefan Siewert has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Klaus-Peter Schmitz

    Institute for ImplantTechnology and Biomaterials e.V., Rostock- Warnemünde , Germany

    5 shared publications
  • Michael Stiehm

    Institute for ImplantTechnology and Biomaterials e.V., Rostock- Warnemünde , Germany

    5 shared publications
  • Thomas Stahnke

    Institute for ImplantTechnology and Biomaterials e.V., Rostock- Warnemünde , Germany

    3 shared publications
  • Wolfram Schmidt

    Institute for Biomedical Engineering, Rostock University Medical Center, Rostock, Germany

    3 shared publications
  • Andrea Bock

    Institute for ImplantTechnology and Biomaterials e.V., Rostock- Warnemünde , Germany

    2 shared publications
  • Ariane Dierke

    Institute for ImplantTechnology and Biomaterials e.V., Rostock- Warnemünde , Germany

    2 shared publications

Latest Publications

  • Open Access

    Development of a standardized intracranial vessel model from 3D time-of-flight magnetic resonance angiography data of the SHIP cohort

    by Antonia Dalmer, Stefan Siewert, Dominique Passler, Hagen Paetow, Christoph Brandt-Wunderlich, Daniel Cantré, Ebba Beller, Sönke Langner, Klaus-Peter Schmitz, Marc-André Weber, et al.

    Purpose: A standardized, population-based three-dimensional (3D) computer-aided design (CAD) model of the intracranial arterial system was developed from time-of-flight magnetic resonance angiography (TOF-MRA) data of the Study of Health in Pomerania (SHIP) cohort, tailored for realistic simulation and experimental neurovascular applications. Methods: An averaged intracranial TOF-MRA dataset generated from 4308 individual whole-body MRI examinations of the SHIP cohort was used as the anatomical basis. Intracranial arteries were segmented using 3D Slicer with Frangi-based vessel enhancement, semi-automatic region-growing, and manual refinement to obtain continuous vascular masks. Centerlines were extracted with VMTK (Vascular Modelling Toolkit) , and vessel radii were computed via distance mapping. The resulting centerline and radius data were imported into a CAD environment ( Creo Parametric ) to reconstruct smooth vessel centerlines, generate circular cross-sections, and create a lofted three-dimensional lumen model, which was converted into a hollow geometry with a uniform wall thickness and exported as an STL file for 3D printing. Results: The proposed workflow yielded a geometrically consistent, hollow 3D model of the central intracranial arteries, representing a population-averaged arterial anatomy with smooth vessel courses, gradual diameter transitions, and a closed, continuous wall. The CAD model could be successfully manufactured as a physical 3D-printed phantom and provides a stable, reproducible test environment for digital and in vitro investigations of neurovascular interventions under standardized anatomical conditions. Conclusions: Population-based TOF-MRA data can be transformed into a technically robust and anatomically meaningful intracranial reference model suitable for CAD-based simulation and additive manufacturing. The resulting 3D CAD geometry serves as a reusable reference for comparative studies, methodological validation, early-stage device development, and training in endovascular neurosurgery, without aiming to replace patient-specific models.

  • Open Access

    FemStent – A Microstructured Polymer Stent for Enhanced Gamete Transport in Proximal Tubal Occlusion

    by Stefan Siewert, Finja Borowski, Swen Grossmann, Ariane Dierke, Michael Stiehm, Andrea Bock, Marek Zygmunt, Klaus-Peter Schmitz

    Proximal Fallopian tube occlusion represents a significant cause of female infertility, limiting natural conception. To address this challenge, we proposed the FemStent previously - a polymer-based, bioresorbable, and self-expanding microstent. To accelerate the epithelialization of the inner stent surface and thus enable safe and uninterrupted passage of gametes, the concept of microstructuring was developed. Corresponding patent applications have been filed (EP 23200861, PCT/EP2024/077397). The current study analyzed the technical feasibility of microstructuring the inner stent surface. For this purpose, stainless steel mandrels were microstructured using femtosecond laser ablation and then used to manufacture tubular semifinished products made of poly-(L-lactide). Microstent prototypes were manufactured by using femtosecond laser cutting of polymer semifinished products with and without a microstructured inner surface. The microstent prototypes were subjected to comprehensive morphological analyses. An in vitro model system for particle tracking was developed to demonstrate the permeability of the fallopian tube stent for gametes. The results demonstrate the technical feasibility of a fallopian tube microstent with a clearly defined microstructured inner surface and provide evidence for improved gamete transport. Future in vitro studies in more elaborate models as well as future in vivo studies will provide further insights into optimizing the microstent's structure and function. This research lays the groundwork for an innovative gynecological intervention, potentially improving fertility outcomes in patients with proximal tubal occlusions in the future.

  • Development of a bioresorbable self-expanding microstent for interventional applications – an innovative approach for stent-assisted coiling

    by Hagen Paetow, Felix Streckenbach, Christoph Brandt-Wunderlich, Wolfram Schmidt, Michael Stiehm, Sönke Langner, Daniel Cantré, Marc-André Weber, Klaus-Peter Schmitz, Stefan Siewert

    Objectives Stent-assisted coiling prevents coil migration in broad-based intracranial aneurysms. So far, only permanent metal stents are approved for intracranial use. Bioresorbable stents allow a new therapeutic approach that may prevent the need for lifelong anticoagulation. We developed a neurovascular bioresorbable microstent (NBRS) and compared it in vitro to the commercial Neuroform EZ stent. Materials and Methods The self-expanding NBRS design is oriented on the Neuroform EZ stent. Poly L-lactic acid (PLLA) was used to manufacture semi-finished products in a dipping process. For the compensation of the inferior material properties of PLLA, design adjustments were made. The NBRS were cut by means of femtosecond (fs) laser and were morphologically and mechanically compared in vitro to the Neuroform EZ stent. In vitro implantation of an NBRS was performed using a complex patient-specific 3D-printed aneurysm model. In addition, an in vitro coiling procedure to assess the stent’s ability to support a coil package was conducted. Results The NBRS could be reproducibly manufactured and had high quality regarding surface morphology. The radial force at the indicated vessel diameter of 3.0 mm was slightly higher for the Neuroform EZ stent compared to the NBRS. The self-expansion ability of the NBRS could be proven. The kink behavior of the NBRS was comparable to that of the Neuroform EZ stent, so no vessel lumen size reduction is expected. The stents showed identical deformation under local compression of 25 % based on the initial diameter, resulting in maximum forces of 24 ± 5 mN (Neuroform EZ) and 8 ± 2 mN (NBRS). The implanted NBRS expanded uniformly, and proper vessel wall adaptation was observed. The NBRS has the ability to retain a coil package. Conclusion This study reported a reproducible manufacturing process for the developed NBRS as well as mechanical and morphological in vitro tests. Furthermore, successful NBRS implantation into a complex patient-specific vessel model was presented as proof of concept. The promising results of this study, also considering the commercial Neuroform EZ stent, support the idea of fully biodegradable microstents for intracranial aneurysm treatment. Key Points Ziel Stent-gestütztes Coiling verhindert die Coilmigration bei breitbasigen, intrakraniellen Aneurysmen. Bislang sind nur permanente Metallstents für intrakranielle Anwendungen zugelassen. Bioresorbierbare Stents ermöglichen einen neuen therapeutischen Ansatz, bei dem die Notwendigkeit einer lebenslangen Antikoagulation vermieden werden könnte. Wir haben einen neurovaskulären bioresorbierbaren Mikrostent (NBRS) entwickelt und in vitro mit dem kommerziellen Neuroform EZ-Stent verglichen. Material und Methoden Das mit computergestützter Design-Software erstellte selbstexpandierende NBRS-Design orientiert sich am Neuroform EZ. Zum Ausgleich unterlegener Materialeigenschaften wurden Designanpassungen vorgenommen. Poly L-Milchsäure (PLLA) wurde zur Herstellung von Halbzeugen im Tauchverfahren verwendet. Die NBRS wurden mittels Femtosekunden (fs)-Laser geschnitten. Darauf aufbauend erfolgten in vitro morphologische und mechanische Untersuchungen sowie ein Benchmark mit dem Neuroform EZ. Eine in vitro Implantation eines NBRS unter Verwendung eines komplexen patientenspezifischen 3D-gedruckten Aneurysma-Modells sowie eine in vitro Coiling-Prozedur zur Bewertung der Rückhaltefähigkeit des NBRS wurden durchgeführt. Ergebnisse Die NBRS konnten reproduzierbar und qualitativ hochwertig hergestellt werden. Der Neuroform EZ zeigte bei einem Einsatzdurchmesser von 3,0 mm eine leicht höhere Radialkraft als der NBRS. Die Selbstaufweitfähigkeit des NBRS wurde nachgewiesen. Das Knickverhalten des NBRS war vergleichbar mit dem Neuroform EZ, sodass keine Reduktion des Gefäßlumens zu erwarten ist. Die Stents zeigten eine identische Verformung unter 25 % lokaler Kompression, bezogen auf den ursprünglichen Durchmesser, was zu maximalen Kräften von 24 ± 5 mN (Neuroform EZ) und 8 ± 2 mN (NBRS) führte. Die Expansion des implantierten NBRS erfolgte gleichmäßig und es wurde eine vollständige Anpassung an die Gefäßwand beobachtet. Die Fähigkeit des NBRS, ein Coil-Paket zurückzuhalten, konnte bestätigt werden. Schlussfolgerung Diese Studie berichtet über einen reproduzierbaren Herstellungsprozess für die entwickelten NBRS sowie mechanische und morphologische in vitro Tests. Darüber hinaus wurde eine erfolgreiche NBRS-Implantation in ein komplexes patientenspezifisches Gefäßmodell als Konzeptnachweis vorgestellt. Die vielversprechenden Ergebnisse dieser Studie, unter Berücksichtigung des kommerziellen Neuroform EZ-Stents, stützen die Idee vollständig bioresorbierbarer Mikrostents für die Behandlung intrakranieller Aneurysmen. Kernaussagen Zitierweise Received: 01 March 2023 Accepted: 09 November 2023 Article published online: 13 December 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Radial compliance of porcine Fallopian tubes ex vivo – perspectives for the development of a gynecological microstent

    by Stefan Siewert, Ariane Dierke, Thomas Stahnke, Swen Großmann, Christoph Brandt-Wunderlich, Laura Supp, Michael Stiehm, Andrea Bock, Klaus-Peter Schmitz, Paula Rosam, et al.

    Fallopian tube occlusions represent one of the most common causes of female sterility. As an innovative treatment approach for affected persons, we previously presented the concept of a novel polymeric, self-expanding, and bioresorbable microstent. As a basis for microstent development, knowledge of the mechanical properties of the anatomical target structure represents a crucial requirement. The current work describes a methodological approach for the experimental determination of radial Fallopian tube compliance using optical coherence tomography. It could be shown that a quantitative assessment of the mechanical properties of porcine Fallopian tube samples - as a whole anatomical structure including the Tunica mucosa, the Tunica muscularis, and the Tunica serosa - is possible, using the described test setup. Future investigations on human samples will allow for valuable information regarding the structural-mechanical properties of the Fallopian tube. Therefore, the current work offers perspectives for the development of a novel gynecological microstent for the treatment of Fallopian tube occlusions.


  • Open Access

    Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies

    by Stefan Siewert, Sabine Kischkel, Andreas Brietzke, Ludmila Kinzel, Tobias Lindner, Ulf Hinze, Boris Chichkov, Wolfram Schmidt, Michael Stiehm, Niels Grabow, et al.

    Purpose: Microinvasive glaucoma surgery (MIGS) has become an important treatment approach for primary open-angle glaucoma, although the safe and long-term effective lowering of intraocular pressure with currently available implants for MIGS is not yet achieved to a satisfactory extent. The study focusses on the development and in vitro and in vivo testing of a novel microstent for MIGS. Methods: A silicone elastomer-based microstent was developed. Implants were manufactured using dip coating, fs-laser cutting, and spray coating. Within the current study no antifibrotic drug was loaded into the device. Sterilized microstents were analyzed in vitro regarding pressure–flow characteristics and biocompatibility. Six New Zealand white rabbits were implanted with a microstent draining the aqueous humor from the anterior chamber into the subconjunctival space. Drainage efficacy was evaluated using oculopressure tonometry as a transient glaucoma model. Noninvasive imaging was performed. Results: Microstents were manufactured successfully and characterized in vitro. Implantation in vivo was successful for four animals with additional device fixation. Without additional fixation, dislocation of microstents was found in two animals. Safe and effective intraocular pressure reduction was observed for the four eyes with correctly implanted microstent during the 6-month trial period. Conclusions: The described microstent represents an innovative treatment approach for MIGS. The incorporation of a selectively antifibrotic drug into the microstent drug-elutable coating will be addressed in future investigations. Translational Relevance: The current preclinical study successfully provided proof of concept for our microstent for MIGS which is suitable for safe and effective intraocular pressure reduction and offers promising perspectives for the clinical management of glaucoma.


  • Open Access

    Femtosecond laser manufacturing technology for microstents as innovative medical devices to treat open-angle glaucoma

    by Stefan Siewert, Eric Bohne, Swen Grossmann, Wolfram Schmidt, Niels Grabow, Thomas Stahnke, Rudolf Guthoff, Michael Stiehm, Klaus-Peter Schmitz

    The increasing trend of minimally invasive therapy methods for widespread diseases in the cardiovascular system, in the field of ophthalmology, ear, nose, and throat medicine, or gynecology, leads to an extensive demand for innovative microdevice manufacturing technologies. Femtosecond (fs)-laser technology offers a wide range of applications in the field of cutting, milling, and surface structuring on the micro- and nanometer scale. Ophthalmic devices for glaucoma therapy have dimensions in the submillimeter range. Irrespective of this, there are high demands on the safety and efficacy of these implants. Within the current study, fs-laser-based manufacturing technologies for functional elements of a novel microstent for glaucoma therapy were developed, considering potential industrial scalability. We successfully developed a mounting mechanism for quick and reproducible manufacturing of a micromechanical valve mechanism for safe regulation of intraocular pressure. Furthermore, we successfully developed a fs-laser-based process for manufacturing grooves as part of a fixation mechanism for a stable device positioning inside the eye. The results show that fs-laser manufacturing represents a promising technology for manufacturers of medical microdevices, such as ophthalmic microstents.